NHS Commissioning Board sets out interim arrangements

pharmafile | March 12, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Hakin, NHS 

The NHS Commissioning Board has announced interim arrangements for the post of chief operating officer and deputy chief executive.

Later this year the Board plans to advertise for a permanent replacement.

Dame Barbara Hakin (pictured), who is currently the Board’s National director for Commissioning Development, will take up the role on a temporary basis from the second half of April.

Rosamond Roughton, the Board’s director of Commissioning Systems and Strategy, will serve as interim National director for Commissioning Development.

The current chief operating officer and deputy chief executive Ian Dalton CBE, announced last month that he is to leave the NHS to be president of Global Health at BT Global Services.

Currently Hakin oversees the development of the new commissioning system, including CCGs and commissioning support units (CSUs).

Previously she spent over 20 years working as a GP in Bradford. She was chief executive of a strategic health authority and a primary care trust. She has held several senior positions with the Department of Health.

Hakin is currently under investigation by the GMC over the recent Mid Staffs scandal.

Ms Roughton was director of Strategy at NHS Yorkshire and Humber Strategic Health Authority and a director of the Christie Hospital NHS Foundation Trust.